# Opus Genetics, Inc. (IRD)

> Source: Nexqual · https://nexqual.com/IRD · data as of 2026-10-15 20:00 UTC · cite as "Nexqual, Opus Genetics, Inc. (IRD), nexqual.com/IRD" · informational, not investment advice.

**Price:** USD 4.05 (-1.22% on the day) · last close of Oct 15, 2026; US market closed, not a live price. Prev close 4.05 · day 3.98–4.28 · 52w 1.7–7.07 · market cap null · NCM

## Key facts
- Analysts: Buy (mean 1.83 on a 1–5 scale) (18 analysts), mean target USD 13.41 (range 8–20).
- Total return with dividends: 1Y +101.5% vs S&P 500 +18.1%; 5Y -5.6% vs S&P 500 +85.1%.
- Next earnings: 2026-11-11, EPS estimate USD -0.15, revenue estimate $2.1M.

## Analysts
Consensus Buy (mean 1.83 on a 1–5 scale), 18 analysts; mean target USD 13.41 (low 8, high 20).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-06 | Jones Trading | Target raised | Buy | $10 → $17 |
| 2026-10-02 | Chardan Capital | Maintained | Buy | $16 |
| 2026-09-10 | Wedbush | Target raised | Outperform | $10 → $13 |
| 2026-09-09 | Oppenheimer | Target raised | Outperform | $10 → $20 |
| 2026-09-09 | HC Wainwright & Co. | Reiterated | Buy | $8 |
| 2026-09-09 | BTIG | Reiterated | Buy | $12 |
| 2026-09-09 | Chardan Capital | Target raised | Buy | $13 → $16 |
| 2026-08-07 | RBC Capital | Target lowered | Outperform | $10 → $9 |
| 2026-07-29 | TD Cowen | Initiated | Buy |  |
| 2026-07-06 | Chardan Capital | Maintained | Buy | $13 |
| 2026-07-06 | BTIG | Reiterated | Buy | $12 |
| 2026-06-18 | Chardan Capital | Target raised | Buy | $11 → $13 |

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-16) | 5Y (from 2021-10-11) |
|---|---|---|
| Total return | +101.5% | -5.6% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | +102.0% | -1.1% |
| Volatility (annualized) | 79.0% | 73.9% |
| Max drawdown | -49.2% (Apr 2026→Jul 2026) | -88.5% (May 2023→Apr 2025) |

## Peers (Biotechnology)
RYTM (Rhythm Pharmaceuticals, Inc.) USD 87.97 +1.57% · BLTE (Belite Bio, Inc) USD 152.62 +0.49% · IOVA (Iovance Biotherapeutics, Inc.) USD 14.72 +1.52% · PRAX (Praxis Precision Medicines, Inc) USD 248.24 +2.01% · IONS (Ionis Pharmaceuticals, Inc.) USD 44.12 +4.11% · SYRE (Spyre Therapeutics, Inc.) USD 80.1 -0.44%

## More
Full page: https://nexqual.com/IRD · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt